Vulnerability Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Intellispace Cardiovascular | <= 3.1 |
| Philips | Xcelera | <= 4.1 |
Related Weaknesses (CWE)
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
FAQ
What is CVE-2018-14789?
CVE-2018-14789 is a vulnerability with a CVSS score of 6.7 (MEDIUM). In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may al...
How severe is CVE-2018-14789?
CVE-2018-14789 has been rated MEDIUM with a CVSS base score of 6.7/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2018-14789?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Intellispace Cardiovascular, Philips Xcelera.